|
PPP1R10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.9958930022126E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.32500019237136E-10 |
| Normal-vs-Stage2 |
5.24659982126252E-10 |
| Normal-vs-Stage3 |
6.98330282489223E-14 |
| Normal-vs-Stage4 |
2.38697950294409E-14 |
| Stage1-vs-Stage2 |
4.345000E-01 |
| Stage1-vs-Stage3 |
6.18079999999965E-05 |
| Stage1-vs-Stage4 |
5.965600E-04 |
| Stage2-vs-Stage3 |
5.954400E-02 |
| Stage2-vs-Stage4 |
2.609900E-02 |
| Stage3-vs-Stage4 |
3.382600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54479762315418E-11 |
| Normal-vs-AfricanAmerican |
1.97209999999171E-05 |
| Normal-vs-Asian |
1.15130016631326E-10 |
| Caucasian-vs-AfricanAmerican |
5.749800E-01 |
| Caucasian-vs-Asian |
8.210000E-01 |
| AfricanAmerican-vs-Asian |
5.790000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.83091344705144E-12 |
| Normal-vs-Female |
1.33080213515768E-11 |
| Male-vs-Female |
5.075800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.96329952295571E-10 |
| Normal-vs-Age(41-60Yrs) |
9.30955312838933E-12 |
| Normal-vs-Age(61-80Yrs) |
4.75175454539567E-14 |
| Normal-vs-Age(81-100Yrs) |
6.633700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.634610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.418500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.550600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.649600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.166200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.438600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.34660005368659E-09 |
| Classical-VS-Follicular |
8.271600E-01 |
| Classical-VS-Other |
7.624400E-01 |
| Classical-VS-Normal |
1.46029965897299E-10 |
| Tall-VS-Follicular |
3.64689999999834E-05 |
| Tall-VS-Other |
1.638020E-01 |
| Tall-VS-Normal |
1.62525548574877E-12 |
| Follicular-VS-Other |
8.550600E-01 |
| Follicular-VS-Normal |
5.53309953410519E-10 |
| Other-VS-Normal |
2.939700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7117973705183E-11 |
| Normal-vs-N1 |
4.95350427343055E-11 |
| N0-vs-N1 |
6.340200E-01 |
|
|
